# Centene Corporation – Consensus ‘buy’ rating and 20.6% Upside Potential

- Link: https://www.directorstalkinterviews.com/centene-corporation-consensus-buy-rating-and-20.6-upside-potential/4121127808
- Published: 2023-09-20T13:43:28+01:00
- Author: Charlotte Edwards

**Centene Corporation** with ticker code (CNC) have now 17 analysts in total covering
the stock. The consensus rating is pointing to ‘buy’. The range between the high
target price and low target price is between 110 and 71 calculating the mean target
price we have $81.82. Given that the stocks previous close was at $67.86 and the
analysts are correct then there would likely be a percentage uptick in value of 
20.6%. Also worth taking note is the 50 day moving average now sits at $66.02 and
the 200 day MA is $69.63. The company has a market cap of 36.74B. The stock price
for the company is currently is currently 67.85 USD

 The potential market cap would be $44,297,278,589 based on the market consensus.

The company has a dividend yield of 1.57%. Other points of data to note are a P/
E ratio of 13.9, revenue per share of 247.62 and a 3.68% return on assets.

Centene Corporation is a healthcare company. The Company provides services to government-
sponsored and commercial healthcare programs, focusing on under-insured and uninsured
individuals. It provides a range of managed healthcare products and services, primarily
through Medicaid, Medicare, and commercial products. Its segments include Medicaid,
Medicare, Commercial and Other. It offers Medicaid and Medicare members (including
Medicare Prescription Drug Plans) as well as individuals and families served by 
the Health Insurance Marketplace and the TRICARE program. It also contracts with
other healthcare and commercial organizations to provide a variety of specialty 
services focused on treating the whole person. Medicaid program provides health 
insurance to low-income families and individuals with disabilities. Medicare is 
a federal health insurance program for people ages 65 and over, which also covers
people under 65 with certain disabilities and people with end-stage renal diseases.

Share on: